Skip to main content
Equibles
FBIO logo

FBIO · Fortress Biotech, Inc. · Metrics

Track FBIO — free

Use FBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.52 -0.05 (-1.95%) At close · Sep 11
Rebalance outlook locked
Market Cap
$92.68M
Shares
36.78M

FBIO metrics

70 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.52
Market cap
$92.68M

Price action

20 metrics
Price change (1W)
-7.4%
Price change (30D)
-15.4%
Price change (3M)
-9.0%
Price change (6M)
-18.7%
Price change (YTD)
-31.1%
Price change (1Y)
-34.2%
Trailing year
Price change (5Y)
—
52-week high
$4.38
52-week low
$2.22
Change from 52-week high
-42.5%
Change from 52-week low
+13.5%
Annualized volatility
73.8%
Annualized volatility (3M)
65.3%
Beta
1.2
RSI (14D)
34.0
Price vs SMA 50
-15.9%
Price vs SMA 200
-16.2%
Avg volume (3M)
579,313
Relative volume
0.4
Average dollar volume
$1.75M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
36.78M

Valuation

12 metrics
P / E (TTM)
1.0
Trailing earnings · reciprocal yield 105.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.4×
reciprocal yield 72.9%
P / book
0.6
reciprocal yield 174.7%
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
0.7
reciprocal yield 134.0%
Earnings yield
119.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.3×
reciprocal yield 43.7%
EV / revenue historical average (5Y)
2.3×
reciprocal yield 43.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-11-14

Profitability

9 metrics
Gross margin
66.9%
Operating margin
-42.6%
Trailing 12 months
Net margin
163.3%
Gross profit (TTM)
—
Operating profit (TTM)
−$29.18M
Net income (TTM)
$111.82M
Trailing 12 months
Diluted EPS (TTM)
$2.70
FCF margin
—
Effective tax rate
3.3%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$4.93

Growth

11 metrics
Revenue growth YoY
+14.0%
Year over year
Net income growth YoY
-103.0%
Revenue (TTM)
$68.47M
Trailing 12 months
EPS growth YoY
-117.8%
Shares change YoY
+6.6%
Year over year · more shares
Revenue CAGR (3Y)
-5.8%
Revenue CAGR (5Y)
+6.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
68.1%
Return on assets
35.3%
Debt / equity
0.2
Current ratio
4.0
EBITDA (TTM)
−$83.94M
Free cash flow (TTM)
—
Quick ratio
3.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$196.58M
Total assets
$316.71M
Total debt
$35.00M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$125.92M
Capital expenditures (TTM)
$0
R&D (TTM)
$1.18M
SG&A (TTM)
$68.68M
Stock compensation (TTM)
$10.29M
R&D / revenue
1.7%
Stock compensation / revenue
15.0%

Ownership (13F)

3 metrics
13F filers
55
13F filer change QoQ
+2
Institutional ownership
17.1%

Short interest

3 metrics
Short interest
14.8%
Latest settlement · 12.0 days to cover
Days to cover
12.0d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1429260 CUSIP 34960Q307 13F (30d) 33 filings 31 filers Visit website Investor relations